Conference Coverage

Low caregiver self-care linked with depression, anxiety


 

FROM THE 2016 ASCO PALLIATIVE CARE IN ONCOLOGY SYMPOSIUM

References

There is increased anxiety and depression among family caregivers who do not take care of themselves, according to a study to be presented at the 2016 ASCO Palliative Care in Oncology Symposium.

Nearly a quarter of 294 caregivers of Medicare patients with advanced cancer reported high depression scores (23%) and 34% reported borderline or high anxiety scores. Worse caregiver anxiety, depression, and mental health–related quality of life scores were significantly associated with lower scores in every self-care measure (P less than .05 for all). Lower self-care behavior scores were associated with longer durations, higher hours, and more days/week of caregiving and with fair or poor patient health.

The cross-sectional survey was conducted in community settings of eight cancer centers in Alabama, Florida, and Tennessee. The family caregivers of Medicare beneficiaries diagnosed with pancreatic, lung, brain, ovarian, head & neck, hematologic, or stage IV cancer completed measures of self-care behaviors, including health responsibility, physical activity, nutrition, spiritual growth, interpersonal relations, stress management, and sleep. Caregivers averaged 66 years and were mostly female (72.8%), white (91.2%), Protestant (76.2%), retired (54.4%), and patients’ spouse/partner (60.2%). Approximately half were rural dwellers (46.9%) and had incomes less than $50,000 (53.8%). The majority provided support 6-7 days per week (71%) for greater than 1 year (68%).

“This research serves as an important call to action for the oncology community to implement support networks and services that care for the caregiver,” ASCO representative Andrew Epstein, MD, of Memorial Sloan Kettering Cancer Center, New York, said in a written statement ahead of the symposium.

“We hope our research rallies the oncology palliative care communities to develop assessment tools and services that support caregivers,” lead author James Nicholas Dionne-Odom, PhD, RN, of the University of Alabama at Birmingham, said in the statement.

jcraig@frontlinemedcom.com

On Twitter @jessnicolecraig

Recommended Reading

Uridine triacetate provides antidote for 5-fluorouracil overdose and toxicity
MDedge Hematology and Oncology
Elotuzumab and ixazomib join the therapeutic arsenal for multiple myeloma
MDedge Hematology and Oncology
Rate of abnormal vaginal bleeding and contraception counseling in women undergoing chemotherapy
MDedge Hematology and Oncology
Effects of IV iron treatment with ferumoxytol on health-related quality of life of patients with iron deficiency anemia
MDedge Hematology and Oncology
Mindfulness-based cancer recovery in survivors recovering from chemotherapy and radiation
MDedge Hematology and Oncology
1,25-dihydroxyvitamin D hypercalcemia and imatinib hepatotoxicity in a patient with GIST
MDedge Hematology and Oncology
Proper treatment of herpes zoster ‘a work in progress’
MDedge Hematology and Oncology
Extended-release granisetron superior antiemetic for cisplatin chemotherapy
MDedge Hematology and Oncology
Pneumonitis with nivolumab treatment shows common radiographic patterns
MDedge Hematology and Oncology
Whole brain radiotherapy not beneficial for NSCLC metastasis
MDedge Hematology and Oncology